scholarly journals Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study

2018 ◽  
Vol 18 (10) ◽  
pp. 2513-2522 ◽  
Author(s):  
Christian Manzardo ◽  
Maria C. Londoño ◽  
LLuís Castells ◽  
Milagros Testillano ◽  
José Luis Montero ◽  
...  
Keyword(s):  
Cohort Study ◽  
Hepatitis C ◽  
Liver Transplant ◽  
Transplant Recipients ◽  
Direct Acting Antivirals ◽  
Direct Acting ◽  
Liver Transplant Recipients

scholarly journals Impact of direct‐acting antivirals for hepatitis C virus therapy on tacrolimus dosing in liver transplant recipients

2019 ◽  
Vol 21 (3) ◽  
pp. e13078 ◽  
Author(s):  
Alexandra L. Bixby ◽  
Linda Fitzgerald ◽  
Rachael Leek ◽  
Jessica Mellinger ◽  
Pratima Sharma ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Liver Transplant ◽  
Transplant Recipients ◽  
Direct Acting Antivirals ◽  
Direct Acting ◽  
Liver Transplant Recipients

scholarly journals Safety and efficacy of current direct-acting antiviral regimens in kidney and liver transplant recipients with hepatitis C: Results from the HCV-TARGET study

Hepatology ◽  
2017 ◽  
Vol 66 (4) ◽  
pp. 1090-1101 ◽  
Author(s):  
Varun Saxena ◽  
Vandana Khungar ◽  
Elizabeth C. Verna ◽  
Josh Levitsky ◽  
Robert S. Brown ◽  
...  
Keyword(s):  
Hepatitis C ◽  
Liver Transplant ◽  
Transplant Recipients ◽  
Safety And Efficacy ◽  
Direct Acting Antiviral ◽  
Direct Acting ◽  
Liver Transplant Recipients
Sign in / Sign up

Export Citation Format

Share Document